Transactions
4
Insider / CVS HEALTH Corp
Nelson Steven H
EVP and President, Aetna at CVS HEALTH Corp
- Company
- CVS HEALTH Corp
- Ticker
- CVS
- First filing on record
- January 27, 2026
- Latest trade on record
- April 1, 2026
- SEC filings
- EDGAR ↗
Nelson Steven H, EVP and President, Aetna at CVS HEALTH Corp, has disclosed 4 transactions in CVS since January 27, 2026: 1 purchase (1 open-market buy) and 1 sale, worth about $12.1M at the reported prices. The latest was filed April 2, 2026, 2 days after the trade; 1 filing was late against the 2-business-day Form 4 deadline.
Open-market buys
1
Sales
1
Avg. disclosure lag
93.5d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months Nelson Steven H made no purchases and 1 sale worth $176K, plus 2 other transactions. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
Nelson Steven H has traded 1 stock on record; the largest by dollars is CVS.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
1 of 2 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| A | Grant or award | 2 | 165,989 | $11.9M |
| F | Shares withheld for tax | 1 | 2,432 | $176K |
| P | Open-market purchase | 1 | 24 | $1,289 |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 3 | 0 | 1 · $176K |
| 2025 | 1 | 1 · $1,289 | 0 |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 143,712 | $72 | $10.3M | derivative | Form 4 ↗ | |
| CVS | Sell F | April 1, 2026 | April 2, 2026 | 1d | 2,432 | $72 | $176K | Form 4 ↗ | ||
| CVS | Other A | March 31, 2026 | April 2, 2026 | 2d | 22,277 | $72 | $1.6M | Form 4 ↗ | ||
| CVS | Buy P | January 23, 2025 | January 27, 2026 | 369d | 24 | $54 | $1,289 | lateindirect | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| April 2, 2026 | Form 4 | 0000064803-26-000041 | 3 | published | EDGAR ↗ |
| January 27, 2026 | Form 4 | 0000064803-26-000004 | 1 | published | EDGAR ↗ |
Other insiders at CVS HEALTH Corp
- Mahoney Michael F Chairman, President & CEO 30 rows
- KIRBY J SCOTT Director 20 rows
- Finucane Anne A. Director 18 rows
- AGUIRRE FERNANDO Director 13 rows
- Newman Brian Director 10 rows
- ROBBINS LARRY Director 10 rows
- FARAH ROGER N Director 9 rows
- CAPOZZI HEIDI B EVP and Chief People Officer 7 rows
- Clark James David SVP, Cont & Chief Acct Officer 5 rows
- Mandadi Tilak EVP, Chief Exp & Tech Officer 5 rows
Everyone on file, with contracts and lobbying under the company's name: CVS HEALTH Corp.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- Options and derivatives on Form 4 Table I = shares. Table II = options and other derivatives.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 2 | 4 | January 27, 2026 | April 2, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.